Avalo Therapeutics (AVTX) Deferred Taxes (2017 - 2026)
Avalo Therapeutics (AVTX) reported Deferred Taxes of $17,000 for Q2 2026, up 6.3% from $16,000 a year earlier and up 41.7% from the prior quarter.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Deferred Taxes (2017 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Avalo Therapeutics' Deferred Taxes came in at $170,000, up 37.1% year-over-year; for FY2025, it came in at $165,000, up 44.7% from FY2024.
- By year, Deferred Taxes came in at $114,000 in FY2024 (+714.3%), $14,000 in FY2023 (-50.0%), $28,000 in FY2022 and -$22,000 in FY2021.
- Five-year quarterly Deferred Taxes spans a low of -$62,000 in Q4 2021 and a high of $131,000 in Q4 2025.
- Year over year, Deferred Taxes has now increased in each of the last three quarters, with growth averaging 42.8% over the last five quarters.
- The high point for year-over-year Deferred Taxes in five years was Q2 2025 (growth of 128.6%); the low point was Q3 2021 (a decline of 98.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $12,000 (Q1 2026), $131,000 (Q4 2025) and $10,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -479.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -195.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -544.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -398.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -291.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -587.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -1.32 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Avalo Therapeutics | 668.42 Mn | 668.42 Mn | - | 17,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17,000.00 |
| Mar 31, 2026 | 12,000.00 |
| Dec 31, 2025 | 131,000.00 |
| Sep 30, 2025 | 10,000.00 |
| Jun 30, 2025 | 16,000.00 |
| Mar 31, 2025 | 8,000.00 |
| Dec 31, 2024 | 114,000.00 |
| Sep 30, 2024 | -14,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Dec 31, 2023 | -9,000.00 |
| Sep 30, 2023 | 8,000.00 |
| Jun 30, 2023 | 7,000.00 |
| Mar 31, 2023 | 8,000.00 |
| Dec 31, 2022 | 8,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 6,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Dec 31, 2021 | -62,000.00 |
| Sep 30, 2021 | 9,000.00 |
API Access
Avalo Therapeutics Deferred Taxes API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=deferred-taxes&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "deferred-taxes", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=deferred-taxes&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();